Statistics for Kezar Life Sciences (id:8266 KZR)
Valuation metrics
Market cap
54.43M
Enterprise value
-91,923,296.00
Trailing P/E (ttm)
-0.54
Forward P/E
-0.71
PEG ratio
-0.71
Price/Sales (ttm)
7.78
Price/Book (mrq)
0.29
Enterprise Value/Revenue
-13.13
Enterprise Value/EBITDA
0.93
Overview
Shares outstanding
7.30M
Float
4.54M
Shares short
177.96K
% Held by insiders
0.15%
% Held by institutions
0.64%
Average volume (10 days)
38.48K
Average volume (90 days)
Price summary
52-Week low
5.20
52-Week high
11.40
52-Week change
-18.67%
Beta
0.22
50-Day moving average
7.20
200-Day moving average
7.46
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
October 30th, 2024
Financials
Fiscal yearFiscal year ends
December 31th, 2023
Most recent quarter (mrq)
June 30th, 2024
Profitability
Profit margin
0.00%
Operating margin
-1,422.01%
Operational effectiveness
Return on assets
-28.07%
Return on equity
-51.48%
Income statement
Revenue (ttm)
0.96
Revenue per share (ttm)
0.96
Quarterly revenue growth (yoy)
Gross profit (ttm)
0.00
EBITDA
-98,462,000.00
Net income to common (ttm)
-98,568,000.00
Diluted EPS (ttm)
-13.50
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
164.18M
Total cash per share (mrq)
22.50
Total debt (mrq)
17.61M
Total Debt/Equity (mrq)
11.69
Current ratio (mrq)
958.10%
Book value per share (mrq)
25.77
Cash flow
Cash flow statement
-79,078,000.00
Levered free cash flow (LFCF)
-41,498,624.00